COMP <GO>
EMBC vs LLY // GROSS PROFIT MARGIN
Embecta Corp. (NASDAQ) VS. Eli Lilly and Company (NYSE) • 15-METRIC TALLY: EMBC 4
— LLY 7
▲ GROSS PROFIT MARGIN LEADER: LLY
LAST: $6.56 (+1.55%) • MKT CAP: $371.7M
gross-margins
62.60%
LAST: $1,373.70 (+6.63%) • MKT CAP: $1.29T
gross-margins
83.64%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EMBC VS. LLY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EMBC | LLY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 62.60% | 83.64% | -21.04 | LLY | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 35.50% | 32.36% | +3.14 | EMBC | /roic <GO> |
| EV/EBITDA & P/E Valuation | 6.1x | 36.4x | -30.32 | EMBC | /valuation <GO> |
| Free Cash Flow Yield | — | 2.30% | — | TIE | /fcf-yield <GO> |
| Operating Margin | 22.40% | 40.21% | -17.81 | LLY | /operating-margins <GO> |
| Net Profit Margin | 8.80% | 31.90% | -23.10 | LLY | /net-margins <GO> |
| Revenue Growth (YoY) | -3.80% | 45.51% | -49.31 | LLY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 9.42% | 0.49% | +8.93 | EMBC | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 9.29 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 9/9 | -2.00 | LLY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.77% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 52.2 | 66.6 | -14.41 | LLY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.51 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 3.6x | 26.3x | -22.65 | EMBC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $371.7M | $1.29T | -$1.29T | LLY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EMBC REV | LLY REV | EMBC GROSS % | LLY GROSS % | EMBC FCF | LLY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.08B | $65.18B | 62.6% | 83.0% | $182.4M | $16.81B |
| FY 2024 | $1.12B | $45.04B | 65.5% | 81.3% | $19.9M | $8.82B |
| FY 2023 | $1.12B | $34.12B | — | 79.3% | $67.7M | $4.24B |
| FY 2022 | — | $28.54B | — | 76.8% | — | $7.59B |
| FY 2021 | — | $28.32B | — | 74.2% | — | $7.37B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EMBC // BETA —
LLY // BETA 0.51